semaglutide

plural semaglutides

1. countableuncountablemedicineA peptide used in the treatment of diabetes and as an antiobesity medication.

   The heart of the growth is semaglutide, Novo Nordisk’s synthetic version of a hormone known as glucagon-like peptide 1, or GLP-1, which helps the body regulate blood sugar levels.

   2024 April 20, Eshe Nelson, Charlotte de la Fuente, “It Introduced Ozempic to the World. Now It Must Remake Itself.”, in The New York Times, →ISSN

   3 more examples

   Last year, the situation began to change when Novo Nordisk received approval from the Food and Drug Administration to market semaglutide. The drug can elicit a 15 percent to 17 percent weight loss in people with obesity.

   2022 April 28, Gina Kolata, “Patients Taking Experimental Obesity Drug Lost More Than 50 Pounds, Maker Claims”, in The New York Times, →ISSN

   But now a new generation of medications has arrived, based on a better understanding of the biological underpinnings of obesity. […] One of these medications – semaglutide, sold under the brand name Wegovy – will soon be available in UK chemists in the form of a weekly, self-administered injection.

   2023 February 23, Jason Halford, “It may be the most effective anti-obesity drug yet – but even Wegovy is no ‘wonder cure’”, in The Guardian, →ISSN

   As semaglutide has skyrocketed in popularity, patients have been sharing curious effects that go beyond just appetite suppression. They have reported losing interest in a whole range of addictive and compulsive behaviors: drinking, smoking, shopping, biting nails, picking at skin.

   2023 May 19, Sarah Zhang, “Ozempic’s Next Act”, in The Atlantic